FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938
- DOI
- 10.3390/ph19030357
- Published
- 2026-02-25
- Container
- Pharmaceuticals
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/ph19030357,
title = {FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938},
author = {Quentin Bruxelles and Geneviève Hamel-Côté and Marie-Pier Scott-Boyer and Vincent Ouellette and René C.-Gaudreault and Francine Durocher and Caroline Diorio and Arnaud Droit and Sébastien Fortin},
year = {2026},
journal = {Pharmaceuticals},
doi = {10.3390/ph19030357},
url = {https://doi.org/10.3390/ph19030357}
}RIS
TY - JOUR TI - FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938 AU - Quentin Bruxelles AU - Geneviève Hamel-Côté AU - Marie-Pier Scott-Boyer AU - Vincent Ouellette AU - René C.-Gaudreault AU - Francine Durocher AU - Caroline Diorio AU - Arnaud Droit AU - Sébastien Fortin PY - 2026 JO - Pharmaceuticals DO - 10.3390/ph19030357 UR - https://doi.org/10.3390/ph19030357 ER -
APA
Bruxelles, Q., Hamel-Côté, G., Scott-Boyer, M., Ouellette, V., C.-Gaudreault, R., Durocher, F., Diorio, C., Droit, A., & Fortin, S. (2026). FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938. Pharmaceuticals. https://doi.org/10.3390/ph19030357
Source records
- crossref · retrieved 2026-09-26T22:02:07.167Z